Additionally, 99% and 84% of sites identified in this study were indeed specific to HL60/MX2 and HL-60 cells, respectively, suggesting that the possibility of m7G methylation is higher in AML-resistant cells than in AML cells. This evidence concerns the gene MX2 and acute myeloid leukemia.